Smac/DIABLO release from the mitochondria and XIAP inhibition are essential to limit clonogenicity of Type I tumor cells after TRAIL receptor stimulation

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• XIAP discriminates between type I and type II FAS-induced apoptosis

  2009cited by this paper
• Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis

  2009cited by this paper
• Caspase-9 Activation by the Apoptosome Is Not Required for Fas-mediated Apoptosis in Type II Jurkat Cells*

  2009cited by this paper
• TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development.

  2008cited by this paper
• A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma

  2008cited by this paper
• Apoptosis regulators Bim and Fas function concurrently to control autoimmunity and CD8+ T cell contraction.

  2008cited by this paper
• Quantitative analysis of pathways controlling extrinsic apoptosis in single cells.

  2008cited by this paper
• Ligand-based targeting of apoptosis in cancer: the potential of recombinant human apoptosis ligand 2/Tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL).

  2008cited by this paper
• (Un)expected roles of c-IAPs in apoptotic and NFkappaB signaling pathways.

  2008cited by this paper
• A Smac mimetic rescue screen reveals roles for inhibitor of apoptosis proteins in tumor necrosis factor-alpha signaling.

  2007cited by this paper
• Apoptosis induction by Bid requires unconventional ubiquitination and degradation of its N-terminal fragment

  2007cited by this paper
• Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family

  2006cited by this paper
• Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma (MM).

  2004cited by this paper
• Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs

  2004cited by this paper
• A large-scale RNAi screen in human cells identifies new components of the p53 pathway

  2004cited by this paper
• The CD95 type I/type II model.

  2003cited by this paper
• Two CD95 tumor classes with different sensitivities to antitumor drugs

  2003cited by this paper
• Bcl-2 and Bcl-xL Inhibit CD95-mediated Apoptosis by Preventing Mitochondrial Release of Smac/DIABLO and Subsequent Inactivation of X-linked Inhibitor-of-Apoptosis Protein*

  2002cited by this paper
• Relief of Extrinsic Pathway Inhibition by the Bid-dependent Mitochondrial Release of Smac in Fas-mediated Hepatocyte Apoptosis*

  2002cited by this paper
• Increased Susceptibility to Tumor Initiation and Metastasis in TNF-Related Apoptosis-Inducing Ligand-Deficient Mice1

  2002cited by this paper
• The expanding role of mitochondria in apoptosis.

  2001cited by this paper
• correction: A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis

  2001cited by this paper
• A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death.

  2001cited by this paper
• Diablo Promotes Apoptosis by Removing Miha/Xiap from Processed Caspase 9

  2001cited by this paper
• Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death

  2001cited by this paper
• Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition.

  2000cited by this paper
• The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues.

  2000cited by this paper
• Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L).

  1999cited by this paper
• Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis

  1999cited by this paper
• The proteolytic procaspase activation network: an in vitro analysis

  1999cited by this paper
• Two CD95 (APO‐1/Fas) signaling pathways

  1998cited by this paper
• Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors.

  1998cited by this paper
• Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9.

  1998cited by this paper
• Differential requirement for caspase 9 in apoptotic pathways in vivo.

  1998cited by this paper
• Apaf1 is required for mitochondrial pathways of apoptosis and brain development.

  1998cited by this paper
• IAPs block apoptotic events induced by caspase‐8 and cytochrome c by direct inhibition of distinct caspases

  1998cited by this paper
• A Sequential Two-Step Mechanism for the Production of the Mature p17:p12 Form of Caspase-3 in Vitro *

  1997cited by this paper
• Bcl–2 protects from lethal hepatic apoptosis induced by an ant–Fas antibody in mice

  1996cited by this paper
• Bcl‐2 and Fas/APO‐1 regulate distinct pathways to lymphocyte apoptosis.

  1995cited by this paper

• A literature review of microRNA and gene signaling pathways involved in the apoptosis pathway of lung cancer

  2023cites this paper
• Catching a killer: Mechanisms of programmed cell death and immune activation in Amyotrophic Lateral Sclerosis

  2022cites this paper
• BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy

  2020cites this paper
• Repurposing of quinoline alkaloids identifies their ability to enhance doxorubicin‐induced sub‐G0/G1 phase cell cycle arrest and apoptosis in cervical and hepatocellular carcinoma cells

  2020cites this paper
• Engeletin suppresses lung cancer progression by inducing apoptotic cell death through modulating the XIAP signaling pathway: A molecular mechanism involving ER stress.

  2020cites this paper
• Characterization of the anti-tumor activity of plants extracts from North Africa: Morocco

  2019cites this paper
• BCL-2 family proteins in apoptosis and its regulation.

  2019cites this paper
• Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins

  2019cites this paper
• XIAP inhibits mature Smac-induced apoptosis by degrading it through ubiquitination in NSCLC

  2016cites this paper
• Mitochondria in Cell Death Regulation

  2016cites this paper
• Original Article Expression of livin, survivin and caspase-3 in prostatic cancer and their clinical significance

  2015cites this paper
• Expression of livin, survivin and caspase-3 in prostatic cancer and their clinical significance.

  2015cites this paper
• Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer

  2015cites this paper
• Kinetic Monte Carlo study of the type1/type 2 choice in apoptosis elucidates selective killing of cancer cells under death ligand induction

  2015cites this paper
• Overcoming Cancer Cell Resistance to Death Receptor Targeted Therapies

  2015cites this paper
• A functional genomics screen identifies PCAF and ADA3 as regulators of human granzyme B-mediated apoptosis and Bid cleavage

  2014cites this paper
• Design, optimization and control in systems and synthetic biology

  2014cites this paper
• Ubiquitination in apoptosis signaling

  2014influential citation
• UvA-DARE ( Digital Academic Repository ) Ubiquitination in apoptosis signaling

  2014cites this paper
• Second mitochondria-derived activator of caspase (SMAC) mimetic potentiates tumor susceptibility toward natural killer cell-mediated killing

  2014cites this paper
• Pulling the plug on a cancer cell by eliminating XIAP with AEG35156.

  2013cites this paper
• STL ‐ based analysis of TRAIL ‐ induced apoptosis challenges the notion of type I / type II cell line classification

  2013cites this paper
• Ubiquitination by MARCH-8 controls TRAIL-R1

  2013cites this paper
• Monte Carlo Study Elucidates the Type 1/Type 2 Choice in Apoptotic Death Signaling in Healthy and Cancer Cells

  2013cites this paper
• SMAC mimetic potentiates tumor susceptibility towards natural killer cell-mediated killing

  2013cites this paper
• STL-based Analysis of TRAIL-induced Apoptosis Challenges the Notion of Type I/Type II Cell Line Classification

  2013cites this paper
• Monte Carlo study elucidates the type 1/type 2 choice in apoptotic death signaling in normal and cancer cells

  2013cites this paper
• Elucidates the Type 1 / Type 2 Choice in Apoptotic Death Signaling in Healthy and Cancer Cells

  2013cites this paper
• Targeting FLIP and Mcl‐1 using a combination of aspirin and sorafenib sensitizes colon cancer cells to TRAIL

  2013cites this paper
• Efficacy and Mechanistic Evaluation of Tic10, A Novel Antitumor Agent

  2012cites this paper
• Regulation of the human TRAIL gene

  2012cites this paper
• Cellular Inhibitor of Apoptosis Protein-1 (cIAP1) Plays a Critical Role in β-Cell Survival under Endoplasmic Reticulum Stress

  2012cites this paper
• Nutrient availability links mitochondria, apoptosis, and obesity

  2012cites this paper
• Caspase-3 cleaves XIAP in a positive feedback loop to sensitize melanoma cells to TRAIL-induced apoptosis

  2011cites this paper
• Measuring and modeling apoptosis in single cells.

  2011cites this paper
• Increased expression but not sensitivity to Fas/CD95 in glioblastoma cells depleted of mitochondrial DNA.

  2010cites this paper
• Clinical Cancer esearch cular Pathways nked Inhibitor of Apoptosis : A Chemoresistance R tor or a Hollow Promise

  2010cites this paper
• X-linked Inhibitor of Apoptosis: A Chemoresistance Factor or a Hollow Promise

  2010cites this paper
• Selective TRAIL-triggered apoptosis due to overexpression of TRAIL death receptor 5 (DR5) in P-glycoprotein-bearing multidrug resistant CEM/VBL1000 human leukemia cells.

  2010cites this paper
• nked Inhibitor of Apoptosis: A Chemoresistance

  2010cites this paper